- Early StageStartup in initial stages
IonPath Funding
Eric Moessinger + 1 more2 investors
Investors of IonPath
Eric Moessinger
Life sciences VC and early-stage investor with focus and expertise in research tools and synthetic biology. Kauffman Fellow. Operational experience; startup utility player. McKinsey. PhD Genetics. BS Physics. Unafraid of category-defying opportunities.
